BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

Mice treated with certain statins intended to decrease blood pressure also experienced drug-induced toxic myopathy, also

Expert replies
by BTGmoderatorDC » Sun Mar 29, 2020 6:49 pm

Timer

00:00

Answers

A

B

C

D

E

Stats

Difficulty

Mice treated with certain statins intended to decrease blood pressure also experienced drug-induced toxic myopathy, also known as muscular degeneration. Scientists hypothesize that this may have occurred because the statins cause an over-activation of creatine kinases, which are known to cause muscular degeneration.

Which of the following experiments would yield the most useful results for analyzing the scientists’ hypothesis?


A. Administering statins to mice with increased creatine kinase activity and observing creatine kinase activity.

B. Injecting mice with a creatine kinase inhibitor before administering the statins and then monitoring muscle tissue response.

C. Injecting mice with creatine kinase inhibitors and then monitoring muscle tissue response.

D. Injecting mice with muscle repair medication and then monitoring levels of muscular response.

E. Measuring mice’s level of muscular myopathy, administering a creatine kinase inhibitor, and then measuring myopathy once more


OA B

Source: Veritas Prep
Join the discussion
Source: — Critical Reasoning |